First Allied Advisory Services’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

First Allied Advisory Services’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$114K	Sell	50,838 -430	-0.8%	-$1.23K	﹤0.01%	1133
2020 Q2	$184K	Buy	51,268 +755	+1%	+$2.72K	0.01%	1021
2020 Q1	$192K	Buy	50,513 +1,389	+3%	+$4.58K	0.01%	948
2019 Q4	$142K	Buy	+49,124	New	+$128K	﹤0.01%	1158

Other funds holding BMY.RT

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

First Allied Advisory Services's BMY.RT Position: Q3 2020 in Review

First Allied Advisory Services reduced its Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) stake by 0.84% in Q3 2020, selling an estimated $1.23K and leaving 50,838 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #1133.

First Allied Advisory Services first reported a position in BMY.RT in Q4 2019 and has held it in 4 quarters since. The position peaked at $192K in Q1 2020. 571 funds tracked by Wall St. Rank hold BMY.RT as of Q3 2020.

First Allied Advisory Services held 50,838 shares of Bristol-Myers Squibb Company Contingent Value Rights worth $114K as of Q3 2020.
First Allied Advisory Services sold 430 Bristol-Myers Squibb Company Contingent Value Rights shares in Q3 2020, an estimated $1.23K.
Bristol-Myers Squibb Company Contingent Value Rights made up ﹤0.01% of First Allied Advisory Services's portfolio in Q3 2020, its #1133 holding.
First Allied Advisory Services first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and has held it in 4 quarters since.
First Allied Advisory Services's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $192K in Q1 2020.
571 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.